Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Heart Failure: Beyond Y2K -- a Prous Science webcast from the AHA

Nov. 11, 1999

News from AHA: photoangioplasty with Antrin is safe and effective for PAD

Nov. 11, 1999

New HOPE for high-risk patients with cardiovascular disease

Nov. 11, 1999

Novel photosensitizer from Miravant prevents postangioplasty restenosis in pig model

Nov. 10, 1999

News from AHA: Bayer presents promising new treatment for atherosclerosis

Nov. 10, 1999

Vasopeptidase inhibitor steals the show at AHA

Nov. 10, 1999

Levosimendan NDA withdrawn for amendment and subsequent refiling

Nov. 9, 1999

News from AHA: novel MMP inhibitor from P&U effective in CHF model in rats

Nov. 9, 1999

AGI-1067 prevents the progression of atherosclerosis independent of its effects on cholesterol

Nov. 9, 1999

European patents cover novel tricyclic sPLA2 inhibitors designed at Lilly

Nov. 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...